NRSN2 and esophageal squamous cell carcinoma: In summary, our data presented herein suggested that the LUESCC/miR-6785-5p/NRSN2 axis plays a pivotal role in ESCC progression, and LUESCC may serve as a diagnostic biomarker and therapeutic target for ESCC patients.